Patents matching “recombinant”

US 7371571

Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore

BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN · Granted May 13, 2008 · Expires May 8, 2028

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 22, 2008 · Expires Apr 17, 2028

US 7354576

Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase

BIOMARIN PHARMACEUTICAL INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

US 7335477

Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Feb 26, 2008 · Expires Feb 21, 2028

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 1, 2008 · Expires Dec 27, 2027

US 7306806

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Dec 11, 2007 · Expires Dec 6, 2027

US 7306808

Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Dec 11, 2007 · Expires Dec 6, 2027

US 7265215

DNA or RNA encoding a recombinant dengue envelope protein

The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2007 · Expires Aug 30, 2027

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 28, 2007 · Expires Aug 23, 2027

US 7256281

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 14, 2007 · Expires Aug 9, 2027

US 7250171

Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Jul 31, 2007 · Expires Jul 26, 2027

US 7247716

Recombinant sequence, its preparation and use

University College Cardiff Consultants Limited · Granted Jul 24, 2007 · Expires Jul 19, 2027

US 7227010

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

The United States of America as represented by the Secretary of the Army · Granted Jun 5, 2007 · Expires May 31, 2027

US 7220419

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2007 · Expires May 17, 2027

US 7214787

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted May 8, 2007 · Expires May 3, 2027

US 7211432

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 1, 2007 · Expires Apr 26, 2027

US 7201902

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection

United States of America as represented by the Secretary of the Air Force · Granted Apr 10, 2007 · Expires Apr 5, 2027

US 7192593

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Mar 20, 2007 · Expires Mar 15, 2027

US 7189393

Recombinant anti-tumor RNAse

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 13, 2007 · Expires Mar 8, 2027

US 7150875

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

The United States of America as represented by the Secretary of the Army · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7118738

Recombinant pox virus for immunization against MUC1 tumor-associated antigen

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 10, 2006 · Expires Oct 5, 2026

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 7081529

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted Jul 25, 2006 · Expires Jul 20, 2026

US 7060466

Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene

The Board of Regents of the University of Oklahoma · Granted Jun 13, 2006 · Expires Jun 8, 2026